Bluejay Diagnostics, Inc. (BJDX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.2M |
| Enterprise Value | -3.84M |
| P/E Ratio | -0.24 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.23 |
| Return On Equity | -1.44 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -6.68M |
| Net Income | -6.85M |
| Diluted EPS | -15.25 |
| Total Cash | 3.68M |
| Total Cash/Share | 8.21 |
| Total Debt | 97,032 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.81 |
| Book Value Per Share | 9.31 |
| 52-Week Change | -39.69 |
| 52-Week High | 16.68 |
| 52-Week Low | 1.62 |
| Moving Average 50 Days | 2.61 |
| Moving Average 200 Days | 4.16 |
| Average Volume | 1.31M |
| Shares Outstanding | 453,541 |
| % Held by Institutions | 13.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | January 29, 2026 |